Position in BSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$336,904
-$171,025 QoQ
Shares Held
5,369
+0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Fayez Sarofim & Co holds $301,439,696 across 6 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,278,314 | $297,474,211 | |
| 2 | MDT |
Medtronic plc
|
13,397 | $1,048,046 | |
| 3 | EW |
Edwards Lifesciences Corp
|
10,071 | $911,022 | |
| 4 | SYK |
Stryker Corp
|
2,417 | $760,967 | |
| 5 | ITGR |
Integer Holdings Corp
|
8,082 | $755,262 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
7,658 | $490,188 |
All Filings in BSX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $336,904 | 5,369 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $507,929 | 5,327 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $520,075 | 5,327 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $560,250 | 5,216 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $569,064 | 5,641 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $477,951 | 5,351 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $317,853 | 3,793 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $979,490 | 12,719 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $871,603 | 12,726 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $735,285 | 12,719 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $741,470 | 14,043 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $276,291 | 5,108 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||